1. Introduction {#s0005}
===============

The impairment of functional outcomes is a core problem in schizophrenia and may worsen subjective and objective quality of life (QOL) for patients. Specifically, subjective QOL is an important patient-reported outcome, reflecting individuals\' perceptions of psychological wellness and satisfaction ([@bb0160]).

Functional outcome is evaluated by some related, but clinically distinct, manifestations such as cognitive function, functional capacity/skills, and social functioning ([@bb0095], [@bb0100]). Cognitive abilities are measured using standardized neuropsychological tests in a laboratory setting. The assessment of functional capacity/skill is associated with an individual\'s ability to manage his or her everyday activities. Accordingly, performance based measures, such as the UCSD Performance-based Skills Assessment (UPSA) and its brief version, the UPSA-B ([@bb0190]), have been developed to evaluate the ability to perform daily activities, including counting money, making calls, and managing medical appointments ([@bb0190], [@bb0215]). Social functioning generally means functioning in the real world, such as independent living, interpersonal relationships, and work ([@bb0110], [@bb0175]). Employment status has been considered as a particularly important functional outcome of individuals with schizophrenia ([@bb0205]).

Reducing psychiatric symptoms, particularly negative symptoms, is also considered to improve QOL, thus enhancing therapeutic alliance and treatment satisfaction ([@bb0150]). Although negative symptoms have been shown to affect QOL in patients with schizophrenia ([@bb0035], [@bb0275]), only a minority of patients exhibit substantial improvement in QOL, even after achieving symptom remission ([@bb0145], [@bb0230]). QOL has also been associated with functional outcomes, including employment status, independent living, engagement in daily activities, and maintaining personal relationships ([@bb0080], [@bb0145]). In sum, cognitive function and psychiatric symptoms are considered to play a major role in social functioning in patients with schizophrenia ([@bb0025]).

General cognitive function is assessed by performance on neuropsychological tests of most cognitive domains ([@bb0060]) and has been shown to correlate with everyday functioning ([@bb0095]). However, a conceptual model of the link between cognitive function and social functioning suggests a discrepancy between cognitive performance in the laboratory setting and community outcomes ([@bb0020], [@bb0100]). Therefore, it is reasonable to assume that functional abilities/capacity, as evaluated by co-primary measures (e.g., UPSA-B), mediates cognitive function and social functioning ([@bb0030], [@bb0090]). Previous studies have shown a role of functional capacity as a mediator of cognitive dysfunctions on employment status ([@bb0030], [@bb0015]).

Although statistical modeling has been employed to examine the relationships among cognitive function, functional abilities, and social functioning (interpersonal skills, community activities, and work skills) ([@bb0030]), there is little information on specifying a model to include pathways to QOL ([@bb0125], [@bb0225]). We seek to extend understandings on pathways to QOL by developing a comprehensive model of the relationships among cognitive function, functional capacity, employment status, psychiatric symptoms, and QOL.

The purpose of this study was to determine clinical predictors of social functioning and QOL in Japanese patients with schizophrenia. We focused on employment status as one of the most important aspects of social functioning. We hypothesized that the effect of cognitive performance on employment status would be mediated by functional abilities, while employment status and negative symptoms would predict QOL.

2. Methods {#s0010}
==========

2.1. Participants {#s0015}
-----------------

A total of 93 patients with schizophrenia (53 male, 40 female) participated in this study. Patients were outpatients treated at the Department of Psychiatry of Osaka University Hospital. A consensus diagnosis, according to Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) criteria, was made by experienced senior psychiatrists using the Structured Clinical Interview for DSM-IV (SCID) for schizophrenia ([@bb0010]). Psychotic symptoms (positive symptoms, negative symptoms, and general psychopathology) were evaluated using the Positive and Negative Syndrome Scale (PANSS) ([@bb0165]).

All participants provided written informed consent after the study procedures were fully explained. All procedures were conducted according to the Declaration of Helsinki and approved by the ethics committee of Osaka University.

2.2. Assessment of cognitive performance {#s0020}
----------------------------------------

Cognitive performance was assessed using a comprehensive neuropsychological battery, which has been employed in previous studies ([@bb0065], [@bb0210]). This included the following cognitive domains: verbal memory, n-back/controlled attention, visual memory, processing speed, card sorting/reasoning, and span/working memory. The following neuropsychological tests were used: the Japanese Adult Reading Test (JART) ([@bb0115], [@bb0185]); the Wechsler Adult Intelligence Scale, Third Edition (WAIS-III) Similarities, Digit Span, Arithmetic, Picture Completion, and Digit Symbol Coding subtests ([@bb0135], [@bb0265]); the Wechsler Memory Scale-Revised (WMS-R) Logical Memory 1, Logical Memory 2, Verbal Paired Association, Visual Paired Association 1, and Visual Paired Association 2 tests ([@bb0235], [@bb0260]); the Continuous Performance Test (CPT, 2--4 digits); the Wisconsin Card Sorting Test (WCST) categories achieved and number of total errors; the Rey Auditory Verbal Learning Tests (AVLT) total recalls (I--V trials); Category Fluency; and Letter Fluency. A general cognitive composite (*g*), was calculated in the same manner, as described in previous studies ([@bb0055], [@bb0065], [@bb0210]). Scores on different measures were converted to *z*-scores using control means and standard deviations (data not shown). Then, *g* composites were derived from the mean of the *z*-scores of the cognitive measures.

2.3. Assessment of functional capacity and social functioning {#s0025}
-------------------------------------------------------------

We assessed functional capacity with the UCSD Performance-based Skills Assessment-brief (UPSA-B) ([@bb0190]). The UPSA-B was developed as an abbreviated version of the UPSA that assesses daily living skills based on role-play performance among patients with mental illnesses ([@bb0215]). The UPSA-B requires a shorter administration time and contains two of the five subdomains of the full version. It measures everyday functional skills of patients using role-play tasks for finance (e.g., counting money and reading a bill) and communication (e.g., dialing a number from memory and calling to reschedule a doctor\'s appointment) ([@bb0190], [@bb0250]). Higher scores indicate greater ability in every-day activities (scores range from 0--100).

Social functioning was assessed using the SFS part included in the modified Social Functioning Scale/Social Adaptation Scale (modified SFS/SAS). The modified SFS/SAS was created in the MATRICS Psychometric and Standardization Studies (MATRICS-PASS; [@bb0105], [@bb0170], [@bb0200]) for the MATRICS Consensus Cognitive Battery. The Japanese version of the modified SFS/SAS was produced by [@bb0245], and its utility was recently reported ([@bb0240]). The SFS part was administered as a self-report questionnaire. Individuals were asked to rate their actual level of activity and ability in areas of social function. Investigators (clinical psychologists or trained research assistants) also reviewed these ratings to confirm the validity of the report. The SFS consists of seven subscales: social engagement, interpersonal communication, independence-performance, independence-competence, recreation, pro-social, and employment/occupation. The SFS total scores were derived from the sum of these subscale scores. Higher scores indicate better real-world functioning in the community. The SFS and the Japanese version were originally developed by [@bb1000], and [@bb0195], respectively.

2.4. Assessment of subjective QOL {#s0030}
---------------------------------

Subjective QOL was evaluated using the Schizophrenia Quality of Life Scale (SQLS). The SQLS is a self-report questionnaire, which provides scores on three subscales: dysfunction of psycho-social activity, dysfunction of motivation/energy, and level of symptoms/side effects ([@bb0270]). Lower scores indicate better QOL. The SQLS has been shown to be reliable, valid, and practical in patients with schizophrenia ([@bb0140]).

2.5. Statistical analyses {#s0035}
-------------------------

We applied path analysis to evaluate path models. The PANSS positive and negative symptoms subscale scores, *g* composite score (general cognitive performance), the UPSA-B total score, and employment/occupation subscale of the SFS, and SQLS were included in the path models. These models were developed through an iterative procedure applied in a previous study ([@bb0030]). The non-significant paths with the smallest contribution to the dependent variable were sequentially removed from a saturated model until the best-fitting model was identified.

We employed *χ*^2^ statistics, a comparative fit index (CFI), and root mean-square error of approximation (RMSEA) with 90% confidence intervals (CIs) to evaluate model fit, as recommended in the literature ([@bb0130]). A good-fitting model was determined by non-significant *χ*^2^ tests, CFI greater than 0.95, and RMSEA less than 0.08. Pearson\'s correlation coefficients were calculated to examine the relationships among subdomains of cognitive function, functional capacity, social functioning, psychiatric symptoms, and QOL. Statistical analyses were performed using SPSS and AMOS 22.0 software (SPSS Japan Inc., Tokyo, Japan).

3. Results {#s0040}
==========

3.1. Analyses of the employment/occupation model {#s0045}
------------------------------------------------

First, we evaluated a model predicting employment status (employment/occupation model), which is a modified version of work skill prediction model of [@bb0030]. In the model, the employment/occupation domain of the SFS was used as the outcome variable. Positive and negative symptoms and the *g* composite were included as independent variables. The UPSA-B total score was included as a mediating variable influencing the effect of the *g* composite on employment/occupation. This model provided a good fit based on a non-significant *χ*^2^ test (*χ*^2^ = 3.6, df = 4, *p* = 0.46) and fit indices (CFI = 1.0; RMSEA \< 0.001, with 90% CIs: 0--0.152) ([Fig. 1](#f0005){ref-type="fig"}). The employment/occupation model adequately satisfied fit criteria, suggesting that functional capacity mediated the relationship between the *g* composite and employment. The employment/occupation domain of the SFS was predicted by negative symptoms (*β* = 0.38, *p* \< 0.001) and functional capacity (*β* = 0.33, *p* \< 0.001), explaining 33% of the variance. Positive symptoms did not influence employment status. Positive and negative symptoms were both moderately related to *g* (*p* \< 0.01). Additionally, we also tested a model using the SFS total score instead of the employment/occupation score. Generally, fit indices indicated a good fit of the model for patients (*χ*^2^ = 6.6, df = 4, *p* = 0.16, CFI = 0.988) with the exception of the RMSEA, which was slightly larger than the threshold criterion for good fit (RMSEA = 0.085, with 90% CIs: 0--0.196). Other models that included the remaining domains of the SFS failed to satisfy good fit criteria or did not show a significant effect of the UPSA-B on the SFS domains (*p* \> 0.05).Fig. 1Employment/occupation model predicting employment status in patients with schizophrenia. The employment/occupation model showed good fit based on fit indices (*χ*^2^ = 3.6, df = 4, *p* = 0.46; CFI = 1.0; RMSEA \< 0.001, with 90% CIs: 0--0.152).

3.2. Analyses of the QOL model {#s0050}
------------------------------

We further evaluated a model in which the subjective QOL was added to the employment/occupation model (QOL model) as a higher-order outcome variable. Because two SQLS subscales, psychosocial and symptoms/side effects, were not predicted by employment status (*β* = − 0.087, *p* = 0.42; *β* = --0.088, *p* = 0.42), they were not included in the QOL model. The motivation/energy subscale fit the QOL model (*χ*^2^ = 10.3, df = 7, *p* = 0.17; CFI = 0.987; RMSEA = 0.072, with 90% CIs: 0--0.159) ([Fig. 2](#f0010){ref-type="fig"}). The SQLS motivation/energy score was predicted by negative symptoms and employment status (*β* = 0.42, *p* \< 0.001; *β* = --0.21, *p* = 0.03), explaining 31% of the variance in SQLS motivation/energy.Fig. 2Quality of life (QOL) model predicting subjective QOL in patients with schizophrenia. The lower scores indicate better QOL in motivation/energy subscale of the Schizophrenia Quality of Life Scale (SQLS). The QOL model showed good fit based on fit indices (*χ*^2^ = 10.3, df = 7, *p* = 0.17; CFI = 0.987; RMSEA = 0.072, with 90% CIs: 0--0.159).

3.3. Correlations among social capacity, social functioning, and other variables {#s0055}
--------------------------------------------------------------------------------

Demographic data, clinical information, and other variables are summarized in [Table 1](#t0005){ref-type="table"}. Correlations between functional capacity, social functioning, cognitive performance, clinical variables, and QOL are presented in [Table 2](#t0010){ref-type="table"}. The UPSA-B scores were correlated with all cognitive measures and psychiatric symptoms. Generally, correlation coefficients between cognitive performance and the UPSA-B (r = 0.3--0.7) were slightly higher than the corresponding coefficients for the SFS (r = 0.2--0.4).Table 1Demographic and clinical characteristics, cognitive performance, functional skills, and social functioning of patients.Mean (SD)DemographicsSex (male/female) (n)53/40Age34.1 (12.0)Education (years)13.8 (2.2)Age at onset23.9 (10.1)Duration of illness (years)10.3 (7.7)Cognitive performanceJART103.3 (9.6)WAIS Similarities8.9 (3.3)WAIS Digit Span9.4 (3.6)WAIS Arithmetic8.4 (3.5)WAIS Picture Completion8.3 (3.8)WAIS Digit Symbol Coding6.9 (3.4)WMS Logical Memory 118.4 (10.4)WMS Logical Memory 214.1 (9.9)WMS Verbal Paired Association17.8 (5.0)WMS Visual Paired Association 113.7 (4.3)WMS Visual Paired Association 25.4 (1.3)CPT Digit 23.5 (0.8)CPT Digit 32.9 (0.9)CPT Digit 42.0 (1.0)WCST Categories Achieved3.6 (1.9)WCST Total Errors19.7 (10.0)AVLT Total46.6 (14.3)Category Fluency16.3 (5.5)Letter Fluency22.0 (8.9)*g*[a](#tf0005){ref-type="table-fn"}− 1.20 (0.98)Functional skillsUPSA-B Total67.1 (17.8)Social functioningSFS Social engagement/withdrawal10.2 (2.3)SFS Interpersonal behavior6.6 (2.9)SFS Pro-social activities11.3 (7.8)SFS Recreation18.7 (6.2)SFS Independence-competence28.3 (7.4)SFS Independence-performance24.0 (7.9)SFS Employment/occupation5.5 (3.8)SFS Total104.6 (29.8)Psychiatric symptomsPANSS Positive18.4 (5.5)PANSS Negative19.9 (5.8)PANSS General psychopathology44.0 (11.3)PANSS Total82.3 (21.6)MedicationCPZeq (mg/day)613.4 (577.4)Subjective QOLSQLS Psychosocial46.1 (23.0)SQLS Motivation/energy52.8 (22.7)SQLS Symptoms/side effects26.5 (18.1)[^1][^2]Table 2Correlations between functional skills, social functioning, cognitive performance, and clinical variables.UPSA-B totalSFS totalEmployment/occupationJART**.418**[⁎⁎](#tf0020){ref-type="table-fn"}**.207**[⁎](#tf0015){ref-type="table-fn"}.050WAIS Similarities**.534**[⁎⁎](#tf0020){ref-type="table-fn"}**.305**[⁎⁎](#tf0020){ref-type="table-fn"}**.227**[⁎](#tf0015){ref-type="table-fn"}WAIS Digit Span**.518**[⁎⁎](#tf0020){ref-type="table-fn"}.184.190WAIS Arithmetic**.649**[⁎⁎](#tf0020){ref-type="table-fn"}**.291**[⁎⁎](#tf0020){ref-type="table-fn"}**.329**[⁎⁎](#tf0020){ref-type="table-fn"}WAIS Picture Completion**.398**[⁎⁎](#tf0020){ref-type="table-fn"}**.393**[⁎⁎](#tf0020){ref-type="table-fn"}**.295**[⁎⁎](#tf0020){ref-type="table-fn"}WAIS Digit Symbol Coding**.496**[⁎⁎](#tf0020){ref-type="table-fn"}**.403**[⁎⁎](#tf0020){ref-type="table-fn"}**.392**[⁎⁎](#tf0020){ref-type="table-fn"}WMS Logical Memory 1**.565**[⁎⁎](#tf0020){ref-type="table-fn"}**.326**[⁎⁎](#tf0020){ref-type="table-fn"}**.254**[⁎](#tf0015){ref-type="table-fn"}WMS Logical Memory 2**.551**[⁎⁎](#tf0020){ref-type="table-fn"}**.325**[⁎⁎](#tf0020){ref-type="table-fn"}**.219**[⁎](#tf0015){ref-type="table-fn"}WMS Verbal Paired Association**.506**[⁎⁎](#tf0020){ref-type="table-fn"}**.352**[⁎⁎](#tf0020){ref-type="table-fn"}**.325**[⁎⁎](#tf0020){ref-type="table-fn"}WMS Visual Paired Association 1**.470**[⁎⁎](#tf0020){ref-type="table-fn"}**.234**[⁎](#tf0015){ref-type="table-fn"}**.310**[⁎⁎](#tf0020){ref-type="table-fn"}WMS Visual Paired Association 2**.358**[⁎⁎](#tf0020){ref-type="table-fn"}**.283**[⁎⁎](#tf0020){ref-type="table-fn"}.187CPT Digit 2**.478**[⁎⁎](#tf0020){ref-type="table-fn"}**.239**[⁎](#tf0015){ref-type="table-fn"}**.292**[⁎⁎](#tf0020){ref-type="table-fn"}CPT Digit 3**.376**[⁎⁎](#tf0020){ref-type="table-fn"}.187.189CPT Digit 4**.331**[⁎⁎](#tf0020){ref-type="table-fn"}.138.133WCST Categories Achieved**.453**[⁎⁎](#tf0020){ref-type="table-fn"}.173**.252**[⁎](#tf0015){ref-type="table-fn"}WCST Total Errors**− .406**[⁎⁎](#tf0020){ref-type="table-fn"}− .185**− .260**[⁎](#tf0015){ref-type="table-fn"}AVLT Total**.514**[⁎⁎](#tf0020){ref-type="table-fn"}**.304**[⁎⁎](#tf0020){ref-type="table-fn"}**.319**[⁎⁎](#tf0020){ref-type="table-fn"}Category Fluency**.389**[⁎⁎](#tf0020){ref-type="table-fn"}**.327**[⁎⁎](#tf0020){ref-type="table-fn"}**.275**[⁎⁎](#tf0020){ref-type="table-fn"}Letter Fluency**.456**[⁎⁎](#tf0020){ref-type="table-fn"}**.393**[⁎⁎](#tf0020){ref-type="table-fn"}**.276**[⁎⁎](#tf0020){ref-type="table-fn"}g[a](#tf0010){ref-type="table-fn"}**.709**[⁎⁎](#tf0020){ref-type="table-fn"}**.423**[⁎⁎](#tf0020){ref-type="table-fn"}**.388**[⁎⁎](#tf0020){ref-type="table-fn"}UPSA-B Total--**.389**[⁎⁎](#tf0020){ref-type="table-fn"}**.486**[⁎⁎](#tf0020){ref-type="table-fn"}PANSS Positive**− .319**[⁎⁎](#tf0020){ref-type="table-fn"}**− .365**[⁎⁎](#tf0020){ref-type="table-fn"}**− .434**[⁎⁎](#tf0020){ref-type="table-fn"}PANSS Negative**− .431**[⁎⁎](#tf0020){ref-type="table-fn"}**− .546**[⁎⁎](#tf0020){ref-type="table-fn"}**− .517**[⁎⁎](#tf0020){ref-type="table-fn"}PANSS General Psychopathology**− .338**[⁎⁎](#tf0020){ref-type="table-fn"}**− .436**[⁎⁎](#tf0020){ref-type="table-fn"}**− .459**[⁎⁎](#tf0020){ref-type="table-fn"}PANSS Total**− .374**[⁎⁎](#tf0020){ref-type="table-fn"}**− .468**[⁎⁎](#tf0020){ref-type="table-fn"}**− .490**[⁎⁎](#tf0020){ref-type="table-fn"}CPZeq (mg/day)**− .269**[⁎](#tf0015){ref-type="table-fn"}**− .217**[⁎](#tf0015){ref-type="table-fn"}**− .255**[⁎](#tf0015){ref-type="table-fn"}SQLS Psychosocial− .173**− .387**[⁎⁎](#tf0020){ref-type="table-fn"}**-.295**[⁎⁎](#tf0020){ref-type="table-fn"}SQLS Motivation/Energy− .164**− .685**[⁎⁎](#tf0020){ref-type="table-fn"}**− .431**[⁎⁎](#tf0020){ref-type="table-fn"}SQLS Symptoms/Side Effects**− .339**[⁎⁎](#tf0020){ref-type="table-fn"}**− .325**[⁎⁎](#tf0020){ref-type="table-fn"}**− .281**[⁎⁎](#tf0020){ref-type="table-fn"}[^3][^4][^5][^6][^7]

4. Discussion {#s0060}
=============

The purpose of this study was to determine the predictors of employment status and subjective QOL and to evaluate the hypothesized model of these relationships for Japanese patients with schizophrenia. To the best of our knowledge, this is the first attempt to construct a comprehensive model including cognitive function, functional capacity, employment status, psychiatric symptoms, and QOL, to investigate complex relationships of the variables using path-modeling approach. Our results support the meditational role of functional capacity in the relationship between cognitive performance and employment status, which leads to better QOL.

The employment/occupation model met the criteria for a good fit, whereas the other model predicting overall social functioning showed slightly larger RMSEA than those required for good fit criteria. The former model successfully explained variables in a manner consistent with a previous study ([@bb0030]). The role of functional capacity, as measured by the UPSA-B, may be important for the employment/occupation domain of social functioning in patients with schizophrenia, as poor cognitive abilities may underlie the deficit patients present in their ability to perform daily activities, which leads to inefficiency in work life ([@bb0120]). These findings suggest an important role of functional capacity as a link between cognitive improvement and employment outcomes ([@bb0020]). Consistent with previous studies ([@bb0030], [@bb0075], [@bb0255]), negative symptoms were found to be moderately associated with cognitive function, social functioning, and QOL. Our model, which included a measure of subjective QOL, indicated that part of QOL may be explained by real-world functioning, which is consistent with previous results ([@bb0080]). These findings suggest that better social functioning (e.g., having a job), is associated with improved subjective QOL in patients with schizophrenia, via increased motivation and energy.

The link between functional capacity and social functioning may be affected by the degree of social support and other environmental factors. While employment status, measured by the SFS, was predicted by performance on the UPSA-B, other components of social functioning (e.g., interpersonal communication and pro-social activities) were not. Enhancement of additional abilities, such as social cognition and adaptive beliefs, may be required for the latter aspects of social functioning to be improved ([@bb0005], [@bb0090]). Moreover, social support, familial resources, financial disadvantage, and previous work history have been reported to affect real-world functioning ([@bb0085], [@bb0180]). Inclusion of these factors may have increased the explanatory power of our model.

Cognitive function was found to be more strongly associated with functional capacity than with social functioning, consistent with previous results ([@bb0070], [@bb0100]). By contrast, cognitive performance was not correlated with social functioning in a set of 106 demographically equivalent healthy control subjects (data not shown), suggesting that patients\' social functioning is more likely to be affected by the level of cognitive function.

Some limitations of the current study should be considered. The cross-sectional nature of this study does not allow us to draw conclusions concerning causal links among functional outcomes, psychiatric symptoms, and QOL. Longitudinal studies are needed to determine the consistency of the models presented here. Second, we employed a self-report measure of QOL; a combination of self-reports and interviewer ratings may have provided a more accurate evaluation of QOL ([@bb0155]). Third, although our model accounted for significant proportions of variance of employment status, other factors, such as assistance from the clinical team as would occur in assertive community treatment ([@bb0045], [@bb0220]), supported employment ([@bb0040], [@bb0050]), public assistance, and family support ([@bb0280]), might account for additional prediction of the variance. Inclusion of these factors may have increased the explanatory power of our model.

In conclusion, the present study provides support for (1) the concept that employment status and negative symptoms predict subjective QOL, i.e., motivation and energy, and (2) the mediating role of functional capacity in the ability of cognitive function to predict employment status. Further research into the relationship between cognitive function and social function may help to develop strategies to alleviate the difficulties faced by patients with schizophrenia.
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[^1]: JART, Japanese Adult Reading Test; WAIS, Wechsler Adult Intelligence Scale-Third Edition; WMS, Wechsler Memory Scale-Revised; CPT, Continuous Performance Test; AVLT, Rey Auditory Verbal Learning Test; WCST, Wisconsin Card Sorting Test; UPSA-B, Brief UCSD Performance-based Skills Assessment; SFS, Social Functioning Scale; PANSS, Positive and Negative Syndrome Scale; CPZeq, chlorpromazine equivalent of total antipsychotics; SQLS, Subjective Quality of Life Scale; and ANCOVA, analysis of covariance (covariates: sex, age, years of education).

[^2]: The "g" composite was derived from the average of the *z*-scores (using control means and standard deviations) of the cognitive measures.

[^3]: Bold values indicate a significant correlation (*p* \< 0.05).

[^4]: JART, Japanese Adult Reading Test; WAIS, Wechsler Adult Intelligence Scale-Third Edition; WMS, Wechsler Memory Scale-Revised; CPT, Continuous Performance Test; AVLT, Rey Auditory Verbal Learning Test; WCST, Wisconsin Card Sorting Test; UPSA-B, Brief UCSD Performance-based Skills Assessment; SFS, Social Functioning Scale; PANSS, Positive and Negative Syndrome Scale; CPZeq, chlorpromazine equivalent of total antipsychotics; and SQLS, Subjective Quality of Life Scale.

[^5]: The "g" composite was derived from the average of the *z*-scores (using control means and standard deviations) of the cognitive measures.

[^6]: *p* \< 0.05.

[^7]: *p* \< 0.01 (2-tailed).
